77863-75-3

Basic information

• Product Name: Benzene, 1-methoxy-3-[(4-nitrophenyl)sulfonyl]-
• CAS NO: 77863-75-3
• Molecular Formula: C13H11NO5S
• Molecular Weight: 293.3
• Mol File: 77863-75-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzene, 1-methoxy-3-[(4-nitrophenyl)sulfonyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-methoxy-3-[(4-nitrophenyl)sulfonyl]-(77863-75-3)
• EPA Substance Registry System: Benzene, 1-methoxy-3-[(4-nitrophenyl)sulfonyl]-(77863-75-3)

Safety Data

• Hazardous Substances Data: 77863-75-3(Hazardous Substances Data)

Upstream product

• 1849-36-1 para-nitrobenzenethiol 
• 350-46-9 4-Fluoronitrobenzene 
• 15570-12-4 3-methoxybenzenethiol 
• 107625-02-5 1-methoxy-3-(4-nitrophenylsulfanyl)benzene 

Downstream Products

• 147696-75-1 4-(3-methoxybenzenesulfonyl)phenylamine 
• 100-32-3 di(p-nitrophenyl) disulfide 
• 77853-08-8 3-Methoxy-benzenethiosulfonic acid; compound with ammonia 
• 100-01-6 4-nitro-aniline 

Relevant articles and documents

Design, synthesis, and structure–activity relationship study of potent mapk11 inhibitors

Huntington’s disease (HD) is a rare single-gene neurodegenerative disease, which can only be treated symptomatically. Currently, there are no approved drugs for HD on the market. Studies have found that MAPK11 can serve as a potential therapeutic target f

Therapeutic amides

Amides having formula I: STR1 wherein E, X, R2 and R3 have the meanings given in the specification, and pharmaceutically acceptable salts and pharmaceutically acceptable in vivo hydrolysable esters thereof, which are useful in the treatment of urinary incontinence. Further provided are processes for preparing the amides and pharmaceutical compositions containing them.